UBX insider transaction filings
Unity Biotechnology, Inc. — 34 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-04-03. Screen UBX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for UBX between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Unity Biotechnology, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-04-03 | 4 | Nguyen Alexander Hieu — CLO and Head of Ops | Sale (S): 17,852 @ $1.03 | EDGAR |
| 2025-04-03 | 4 | Sullivan Lynne Marie — CFO & Head of Corp. Dev. | Sale (S): 21,867 @ $1.03 | EDGAR |
| 2025-04-03 | 4 | Ghosh Anirvan — Chief Executive Officer, Director | Sale (S): 96,797 @ $1.03 | EDGAR |
| 2025-03-31 | 4 | Nguyen Alexander Hieu — CLO and Head of Ops | Sale (S): 1,954 @ $1.16 · Grant/award (A): 44,000 @ $0 · Grant/award (A): 73,000 (derivative) @ $0 | EDGAR |
| 2025-03-31 | 4 | Sullivan Lynne Marie — CFO & Head of Corp. Dev. | Grant/award (A): 65,000 @ $0 · Grant/award (A): 106,000 (derivative) @ $0 | EDGAR |
| 2025-03-31 | 4 | Ghosh Anirvan — Chief Executive Officer, Director | Grant/award (A): 175,000 @ $0 · Grant/award (A): 286,000 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Hashad Yehia — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-05 | 4 | Sullivan Lynne Marie — CFO & Head of Corp. Dev. | Sale (S): 153 @ $2.23 | EDGAR |
| 2025-02-05 | 4 | Nguyen Alexander Hieu — CLO and Head of Ops | Sale (S): 164 @ $2.23 | EDGAR |
| 2025-02-05 | 4 | Ghosh Anirvan — Chief Executive Officer, Director | Sale (S): 642 @ $2.23 | EDGAR |
| 2025-01-23 | 4 | Nguyen Alexander Hieu — CLO and Head of Ops | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Sullivan Lynne Marie — CFO & Head of Corp. Dev. | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Ghosh Anirvan — Chief Executive Officer, Director | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Grossi Federico — Chief Medical Officer | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-11-06 | 4 | Sullivan Lynne Marie — CFO & Head of Corp. Dev. | Sale (S): 136 @ $1.29 | EDGAR |
| 2024-11-06 | 4 | Nguyen Alexander Hieu — Chief Legal Officer | Sale (S): 149 @ $1.29 | EDGAR |
| 2024-11-06 | 4 | Ghosh Anirvan — Chief Executive Officer, Director | Sale (S): 432 @ $1.29 | EDGAR |
| 2024-08-06 | 4 | Nguyen Alexander Hieu — Chief Legal Officer | Sale (S): 154 @ $1.53 | EDGAR |
| 2024-08-06 | 4 | Ghosh Anirvan — Chief Executive Officer, Director | Sale (S): 604 @ $1.53 | EDGAR |
| 2024-08-06 | 4 | Sullivan Lynne Marie — CFO & Head of Corp. Dev. | Sale (S): 139 @ $1.53 | EDGAR |
| 2024-06-26 | 4 | Nguyen Alexander Hieu — Chief Legal Officer | Sale (S): 78 @ $1.40 | EDGAR |
| 2024-06-26 | 4 | Ghosh Anirvan — Chief Executive Officer, Director | Sale (S): 1,214 @ $1.40 | EDGAR |
| 2024-06-26 | 4 | Sullivan Lynne Marie — CFO & Head of Corp. Dev. | Sale (S): 324 @ $1.40 | EDGAR |
| 2024-06-21 | 4 | Roberts Margo R — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | O'Neill Gilmore Neil — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Samar Michael P. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | David Nathaniel E — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Leonard Keith R — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Samuels Camille D — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | BERNS PAUL L — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Ghosh Anirvan — Chief Executive Officer, Director | Sale (S): 603 @ $1.55 | EDGAR |
| 2024-03-27 | 4 | Nguyen Alexander Hieu — Chief Legal Officer | Grant/award (A): 20,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Ghosh Anirvan — Chief Executive Officer, Director | Sale (S): 680 @ $1.71 | EDGAR |
| 2024-01-31 | 4 | Ghosh Anirvan — Chief Executive Officer, Director | Sale (S): 1,183 @ $1.71 | EDGAR |
Recent 8-K events — Unity Biotechnology, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-09-26 | 8-K | 1.02 — Termination of a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-07-24 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-30 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-20 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-05-05 | 8-K | ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-03-24 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=UBX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →